메뉴 건너뛰기




Volumn 20, Issue 5-6, 2001, Pages 666-687

Vaccine prevention of meningococcal disease, coming soon?

Author keywords

Meningococcal vaccines; Protein polysaccharide conjugate; Serogroup B

Indexed keywords

BACTERIAL ANTIGEN; LIPOPOLYSACCHARIDE; MENINGOCOCCUS GLYCOCONJUGATE VACCINE; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE VESICLE VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

EID: 0035852272     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00410-8     Document Type: Review
Times cited : (106)

References (201)
  • 2
    • 0031935304 scopus 로고    scopus 로고
    • Bacterial meningitis in children and adults: Changes in community-acquired disease may affect patient care
    • (1998) Postgrad Med , vol.103 , Issue.3 , pp. 102-117
    • Phillips, E.J.1    Simor, A.E.2
  • 9
    • 0030997865 scopus 로고    scopus 로고
    • Microevolution and epidemic spread of serogroup A Neisseria meningitidis - A review
    • (1997) Gene , vol.192 , Issue.1 , pp. 135-140
    • Achtman, M.1
  • 14
    • 0033863076 scopus 로고    scopus 로고
    • Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: Implication for the composition of a recombinant TbpB-based vaccine
    • (2000) Infect Immun , vol.68 , Issue.9 , pp. 4938-4947
    • Rokbi, B.1    Renauld-Mongenie, G.2    Mignon, M.3
  • 18
    • 0022460060 scopus 로고
    • Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers
    • (1986) J Gen Microbiol , vol.132 , Issue.PART 3 , pp. 641-652
    • Caugant, D.A.1    Bovre, K.2    Gaustad, P.3
  • 23
    • 0033000992 scopus 로고    scopus 로고
    • Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-1996: European meningitis surveillance group
    • (1999) Epidemiol Infect , vol.122 , Issue.1 , pp. 41-49
    • Connolly, M.1    Noah, N.2
  • 26
    • 0029617663 scopus 로고
    • Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37
    • (1995) Cent Eur J Public Health , vol.3 , Issue.4 , pp. 189-194
    • Krizova, P.1    Musilek, M.2
  • 27
    • 0028815815 scopus 로고
    • The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: Emergence of a virulent clone of Neisseria meningitidis
    • (1995) JAMA , vol.273 , Issue.5 , pp. 390-394
    • Whalen, C.M.1    Hockin, J.C.2    Ryan, A.3    Ashton, F.4
  • 33
    • 0034220572 scopus 로고    scopus 로고
    • Annual report of the Australian meningococcal surveillance programme, 1999
    • (2000) Commun Dis Intell , vol.24 , Issue.7 , pp. 181-189
  • 36
    • 0026443050 scopus 로고
    • Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China
    • (1992) Infect Immun , vol.60 , Issue.12 , pp. 5267-5282
    • Wang, J.F.1    Caugant, D.A.2    Li, X.3
  • 40
    • 0033611934 scopus 로고    scopus 로고
    • Epidemic serogroup B meningococcal disease in Oregon: The evolving epidemiology of the ET-5 strain
    • (1999) JAMA , vol.281 , Issue.16 , pp. 1493-1497
    • Diermayer, M.1    Hedberg, K.2    Hoesly, F.3
  • 59
    • 0019482390 scopus 로고
    • Meningococcemia caused by serogroup W135: Association with hypogammaglobulinemia
    • (1981) Arch Int Med , vol.141 , Issue.5 , pp. 664-665
    • Salit, I.E.1
  • 62
    • 0007646777 scopus 로고
    • A report on antimeningitis vaccination and observations on agglutinins in the blood of chronic meningococcus carriers
    • (1918) J Exp Med , vol.28 , pp. 449-474
    • Gates, F.L.1
  • 65
    • 0002440911 scopus 로고
    • The control of meningococcic epidemics by active immunisation with meningococcal soluble toxin: A preliminary report
    • (1936) JAMA , vol.107 , pp. 5-11
    • Kuhns, D.1
  • 69
    • 0020518256 scopus 로고
    • Antigenic similarities between brain components and bacteria causing meningitis: Implications for vaccine development and pathogenesis
    • (1983) Lancet , vol.2 , Issue.8346 , pp. 355-357
    • Finne, J.1    Leinonen, M.2    Makela, P.H.3
  • 71
    • 85025413501 scopus 로고
    • Studies on meningococcus infection. VIII. The type I specific substance
    • (1935) J Exp Med , vol.61 , pp. 753-769
    • Scherp, H.1    Rake, G.2
  • 75
    • 0014528516 scopus 로고
    • Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
    • (1969) J Exp Med , vol.129 , Issue.6 , pp. 1349-1365
    • Gotschlich, E.C.1    Liu, T.Y.2    Artenstein, M.S.3
  • 87
    • 0034616767 scopus 로고    scopus 로고
    • Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial
    • (2000) JAMA , vol.283 , Issue.21 , pp. 2795-2801
    • MacLennan, J.M.1    Shackley, F.2    Heath, P.T.3
  • 90
    • 0019925358 scopus 로고
    • Measurement of antibodies to meningococcal group B polysaccharide: Low avidity binding and equilibrium binding constants
    • (1982) J Immunol , vol.129 , Issue.5 , pp. 2172-2178
    • Mandrell, R.E.1    Zollinger, W.D.2
  • 92
    • 0029875330 scopus 로고    scopus 로고
    • Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children: A randomized controlled trial
    • (1996) JAMA , vol.275 , Issue.19 , pp. 1499-1503
    • Lieberman, J.M.1    Chiu, S.S.2    Wong, V.K.3
  • 93
    • 0033529658 scopus 로고    scopus 로고
    • Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood
    • (1999) Vaccine , vol.17 , Issue.23-24 , pp. 3086-3093
    • MacLennan, J.1    Obaro, S.2    Deeks, J.3
  • 94
    • 0034624087 scopus 로고    scopus 로고
    • A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants
    • (2000) Vaccine , vol.19 , Issue.9-10 , pp. 1232-1238
    • English, M.1    MacLennan, J.M.2    Bowen-Morris, J.M.3
  • 98
    • 0035077458 scopus 로고    scopus 로고
    • Evaluation of de-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: Reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and de-O-acetylated serogroup C strains
    • (2001) Infect Immun , vol.69 , Issue.4 , pp. 2378-2382
    • Richmond, P.1    Borrow, R.2    Findlow, J.3
  • 101
    • 0007641367 scopus 로고    scopus 로고
    • Invasive meningococcal infections, England and Wales
    • (2000) CDR Weekly , vol.10 , Issue.47 , pp. 418
  • 108
    • 0033592235 scopus 로고    scopus 로고
    • Meningococcal conjugate vaccines: New opportunities and new challenges
    • (1999) Lancet , vol.354 , Issue.9179 , pp. 615-616
    • Maiden, M.C.1    Spratt, B.G.2
  • 110
    • 0031029970 scopus 로고    scopus 로고
    • Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys
    • (1997) Infect Immun , vol.65 , Issue.3 , pp. 1045-1052
    • Devi, S.J.1    Zollinger, W.D.2    Snoy, P.J.3
  • 112
    • 0018379184 scopus 로고
    • Development of antibodies to meningococcal protein and lipopolysaccharide serotype antigens in healthy-carriers
    • (1979) J Med Microbiol , vol.12 , Issue.1 , pp. 107-111
    • Jones, D.M.1    Eldridge, J.2
  • 115
    • 0029069384 scopus 로고
    • Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile Chilean National Committee for meningococcal disease
    • (1995) Vaccine , vol.13 , Issue.9 , pp. 821-829
    • Boslego, J.1    Garcia, J.2    Cruz, C.3
  • 116
    • 0033611936 scopus 로고    scopus 로고
    • Immunogenicity of two serogroup B outer-membrane protein meningococcal vaccines: A randomized controlled trial in Chile
    • (1999) JAMA , vol.281 , Issue.16 , pp. 1520-1527
    • Tappero, J.W.1    Lagos, R.2    Ballesteros, A.M.3
  • 127
    • 0022519159 scopus 로고
    • Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine
    • (1986) J Immunol , vol.137 , Issue.5 , pp. 1708-1713
    • Jennings, H.J.1    Roy, R.2    Gamian, A.3
  • 130
    • 15144360247 scopus 로고    scopus 로고
    • Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid
    • (1998) J Immunol , vol.160 , Issue.10 , pp. 5028-5036
    • Granoff, D.M.1    Bartoloni, A.2    Ricci, S.3
  • 133
    • 0033986926 scopus 로고    scopus 로고
    • Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library
    • (2000) Vaccine , vol.18 , Issue.13 , pp. 1253-1263
    • Grothaus, M.C.1    Srivastava, N.2    Smithson, S.L.3
  • 136
    • 0021752688 scopus 로고
    • Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model
    • (1984) Infect Immun , vol.46 , Issue.2 , pp. 408-414
    • Wang, L.Y.1    Frasch, C.E.2
  • 137
    • 0015853721 scopus 로고
    • Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis
    • (1973) J Exp Med , vol.138 , Issue.5 , pp. 1156-1167
    • Devoe, I.W.1    Gilchrist, J.E.2
  • 138
    • 0019975621 scopus 로고
    • Protection against group B Neisseria meningitidis disease: Preparation of soluble protein and protein-polysaccharide immunogens
    • (1982) Infect Immun , vol.37 , Issue.1 , pp. 271-280
    • Frasch, C.E.1    Peppler, M.S.2
  • 139
    • 0034623975 scopus 로고    scopus 로고
    • Immunogenicity and safety of monovalent P1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: Comparison of two vaccination schedules and two vaccine formulations
    • (2000) Vaccine , vol.19 , Issue.9-10 , pp. 1141-1148
    • De Kleijn, E.D.1    De Groot, R.2    Lafeber, A.B.3
  • 145
  • 147
    • 0031816226 scopus 로고    scopus 로고
    • Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial
    • (1998) Infect Immun , vol.66 , Issue.7 , pp. 3223-3231
    • Wedege, E.1    Hoiby, E.A.2    Rosenqvist, E.3    Bjune, G.4
  • 152
    • 0030197578 scopus 로고    scopus 로고
    • Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
    • (1996) Vaccine , vol.14 , Issue.10 , pp. 1001-1008
    • Claassen, I.1    Meylis, J.2    Van der Ley, P.3
  • 153
    • 0033523057 scopus 로고    scopus 로고
    • Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
    • (1999) Vaccine , vol.17 , Issue.20-21 , pp. 2612-2619
    • Cartwright, K.1    Morris, R.2    Rumke, H.3
  • 154
    • 0033971102 scopus 로고    scopus 로고
    • Immunogenicity and safety of a hexavalent meningococcal outer membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
    • (2000) Vaccine , vol.18 , Issue.15 , pp. 1456-1466
    • De Kleijn, E.D.1    De Groot, R.2    Labadie, J.3
  • 157
    • 0027378504 scopus 로고
    • Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals
    • (1993) Vaccine , vol.11 , Issue.12 , pp. 1214-1220
    • Danve, B.1    Lissolo, L.2    Mignon, M.3
  • 160
    • 0035119318 scopus 로고    scopus 로고
    • Recombinant Neisseria meningitidis transferrin binding protein a protects against experimental meningococcal infection
    • (2001) Infect Immun , vol.69 , Issue.3 , pp. 1561-1567
    • West, D.1    Reddin, K.2    Matheson, M.3
  • 165
    • 0024456268 scopus 로고
    • Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease
    • (1989) APMIS , vol.97 , Issue.9 , pp. 774-780
    • Maeland, J.A.1    Wedege, E.2
  • 166
    • 0027499671 scopus 로고
    • The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes
    • (1993) J Infect Dis , vol.167 , Issue.4 , pp. 966-970
    • Estabrook, M.M.1    Baker, C.J.2    Griffiss, J.M.3
  • 178
    • 0031736406 scopus 로고    scopus 로고
    • Immunisation with recombinant class 1 outer-membrane protein from Neisseria meningitidis: Influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci
    • (1998) Microbiology , vol.144 , Issue.PART 11 , pp. 3027-3037
    • Christodoulides, M.1    Brooks, J.L.2    Rattue, E.3    Heckels, J.E.4
  • 181
    • 0032038675 scopus 로고    scopus 로고
    • Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans
    • (1998) Infect Immun , vol.66 , Issue.4 , pp. 1334-1341
    • Haneberg, B.1    Dalseg, R.2    Wedege, E.3
  • 185
    • 0034531987 scopus 로고    scopus 로고
    • Production and characterization of a new monoclonal antibody against Neisseria meningitidis: Study of the cross-reactivity with different bacterial genera
    • (2000) Hybridoma , vol.19 , Issue.6 , pp. 445-453
    • De Gaspari, E.N.1
  • 188
    • 0024456268 scopus 로고
    • Serum antibodies tocross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease
    • (1989) APMIS , vol.97 , pp. 774-780
    • Mæland, J.1    Wedege, E.2
  • 190
    • 0032210729 scopus 로고    scopus 로고
    • Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine
    • (1998) Vaccine , vol.16 , Issue.19 , pp. 1842-1849
    • Fusco, P.C.1    Michon, F.2    Laude-Sharp, M.3
  • 191
    • 0032709595 scopus 로고    scopus 로고
    • Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults
    • (1999) Vaccine , vol.18 , Issue.7-8 , pp. 641-646
    • Richmond, P.1    Goldblatt, D.2    Fusco, P.C.3
  • 192
    • 0033828350 scopus 로고    scopus 로고
    • Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines
    • (2000) Clin Diagn Lab Immunol , vol.7 , Issue.5 , pp. 764-768
    • Sikkema, D.J.1    Friedman, K.E.2    Corsaro, B.3
  • 194
    • 0031032906 scopus 로고    scopus 로고
    • Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains
    • (1997) Infect Immun , vol.65 , Issue.1 , pp. 55-63
    • Rokbi, B.1    Mignon, M.2    Maitre-Wilmotte, G.3
  • 198
    • 0034599411 scopus 로고    scopus 로고
    • Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B
    • (2000) J Immunol Meth , vol.237 , Issue.1-2 , pp. 73-84
    • Plested, J.S.1    Gidney, M.A.2    Coull, P.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.